By Andrew Silver SHANGHAI (Reuters) -Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

In response, Novo is reorganizing its leadership team following the surprise ouster of Chief Executive Lars Fruergaard ...

Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...

The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

Khloé Kardashian has never shied away from sharing her health journey.

Novo Nordisk A/S and Eli Lilly & Co, the pharmaceutical giants dominating the global obesity drug market, now face their ...

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...